GEU20091511Y - Bacteriophage medical means - Google Patents

Bacteriophage medical means

Info

Publication number
GEU20091511Y
GEU20091511Y GEAU200710197U GEAU2007010197U GEU20091511Y GE U20091511 Y GEU20091511 Y GE U20091511Y GE AU200710197 U GEAU200710197 U GE AU200710197U GE AU2007010197 U GEAU2007010197 U GE AU2007010197U GE U20091511 Y GEU20091511 Y GE U20091511Y
Authority
GE
Georgia
Prior art keywords
bacteriophage
medical means
medical
mastitis
cows
Prior art date
Application number
GEAU200710197U
Inventor
Tamara Kalandarishvili
Manana Loladze
George Melashvili
Kakha Didebulidze
Dali Maglakelidze
Manana Nadiradze
Natela Chakhunashvili
Lamara Chanishvili
Taras Gabisonia
Original Assignee
Taras Gabisonia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taras Gabisonia filed Critical Taras Gabisonia
Priority to GEAU200710197U priority Critical patent/GEU20091511Y/en
Priority to PCT/GE2008/000007 priority patent/WO2009016418A2/en
Publication of GEU20091511Y publication Critical patent/GEU20091511Y/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A medical means contains therapeutically effective amount of phage lysates of staphylococcus, streptococcus and colon bacillus and is used for treatment of a mastitis at cows.
GEAU200710197U 2007-07-27 2007-07-27 Bacteriophage medical means GEU20091511Y (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GEAU200710197U GEU20091511Y (en) 2007-07-27 2007-07-27 Bacteriophage medical means
PCT/GE2008/000007 WO2009016418A2 (en) 2007-07-27 2008-07-18 Therapeutic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAU200710197U GEU20091511Y (en) 2007-07-27 2007-07-27 Bacteriophage medical means

Publications (1)

Publication Number Publication Date
GEU20091511Y true GEU20091511Y (en) 2009-07-10

Family

ID=40304967

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAU200710197U GEU20091511Y (en) 2007-07-27 2007-07-27 Bacteriophage medical means

Country Status (2)

Country Link
GE (1) GEU20091511Y (en)
WO (1) WO2009016418A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013106455A1 (en) 2013-06-20 2014-12-24 Airbus Defence and Space GmbH Method for decontamination of bacteriological contaminants
CN108103029B (en) * 2017-12-12 2020-11-10 江苏省农业科学院 Bacteriophage capable of cleaving bovine streptococcus agalactiae and application thereof

Also Published As

Publication number Publication date
WO2009016418A2 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
WO2007130655A3 (en) Phage derived antimicrobial activities
IL250858A0 (en) Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
MX351589B (en) Oxazolidinone antibiotics.
HK1078806A1 (en) Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
HK1138184A1 (en) Combination medicaments for treating bacterial infections
HK1140940A1 (en) Titration of tapentadol
MX2010008921A (en) Oxazolidinone derivatives.
WO2018208987A3 (en) Antibacterial compounds
NZ593111A (en) Antibacterial compounds
ZA201100705B (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
EP2563371A4 (en) Anti-bacterial applications of poly -n-acetylglucosamine nanofibers
MX2009011712A (en) Enhanced formulations of lamotrigine.
MX2021003084A (en) Antibacterial compounds.
NZ594675A (en) Actagardine derivatives
NO20061127L (en) New use of quinolone antibiotics
WO2016142445A3 (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
DE502005010850D1 (en) ANTIBACTERIAL AMID MACROCYCLES IV
EP4007759A4 (en) Beta-lactam compounds, their preparation and use as antibacterial agents
GEU20091511Y (en) Bacteriophage medical means
NO20092496L (en) New therapeutic application for the treatment of leukemia
MX2019006086A (en) Use of a bacterial composition for treating foot infections of ungulates.
NZ594945A (en) Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
EP4062844A4 (en) Endoscopic cap, endoscopic treatment tool, and endoscope system
GB0724996D0 (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
GEP20207136B (en) Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition